Disc Medicine Rare Disease Drug Picked for Faster Regulatory Review Is Rejected by the FDA

Disc Medicine’s effort to introduce a new therapy for a rare blood disorder with few treatment options has been derailed with the FDA turning down the application and asking for more data from another clinical trial. The company is positioned to gather those data for its drug, bitopertin. A confirmatory study was already underway when […]